[Interpretation of the 2021 American Academy of Allergy, Asthma and Immunology expert consensus on the treatment of postinfectious olfactory dysfunction].
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
; 37(2): 81-86, 2023 Feb.
Artículo
en Chino
| MEDLINE | ID: covidwho-20236516
ABSTRACT
Respiratory tract viruses are the second leading cause of olfactory dysfunction. Between 2019 to 2022, the world has been plagued by the problem of olfaction caused by the COVID-19. As we learn more about the impact of severe acute respiratory syndrome coronavirus 2ï¼SARS-CoV-2ï¼, with the recognition that olfactory dysfunction is a key symptom of this disease process, there is a greater need than ever for evidence-based management of postinfectious olfactory dysfunctionï¼PIODï¼. The Clinical Olfactory Working Group has proposed theconsensus on the roles of PIOD. This paper is the detailed interpretation of the consensus.
Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Asma
/
COVID-19
/
Hipersensibilidad
/
Trastornos del Olfato
Tipo de estudio:
Estudio pronóstico
Tópicos:
Covid persistente
Límite:
Humanos
País/Región como asunto:
America del Norte
Idioma:
Chino
Revista:
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
Año:
2023
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS